Tag: glycomics

Op-ed: Glycomics is the new frontier in bioinnovation

Op-ed: Glycomics is the new frontier in bioinnovation

Read about the future of glycomics in this op ed by GlycoNet board chair Karimah Es Sabar, republished from the Hill Times. Canada has a tremendous opportunity with continued investment in glycomics to establish global leadership and economic prosperity while at the same time solving some of the world’s most pressing challenges in health and environmental sustainability.

Glyco-oncology discussion concluded with success

Glyco-oncology discussion concluded with success

By Chardelle Prevatt On Monday, September 19, 2016, GlycoNet scientists joined an elite group of industry experts in Montréal to discuss glycomics and oncology (glyco-oncology).  Featuring Dr. Greg Plowman, VP (oncology research) at Eli Lilly and Company; Dr. Fred Sweeney, VP (business development and strategic alliances) at bioMerieux; and Dr. Luc Marengere, Managing Partner of TVM Capital Life Science, the panel offered invaluable […]

en_USEnglish
Scroll to Top